California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

July 29, 2024

Study Completion Date

July 29, 2024

Conditions

Hemorrhagic ShockTrauma Injury

Interventions

DRUG

Tranexamic Acid

1 gram of prehospital Tranexamic Acid

All Listed Sponsors

lead

Arrowhead Regional Medical Center

OTHER

NCT03469947 - California Prehospital and In Hospital Antifibrinolytic Therapy Via TXA | Biotech Hunter | Biotech Hunter